ImmunArray Ltd

 Company Summary:
  • ImmunArray Ltd is an early commercial stage diagnostics company with the ability to rapidly develop new diagnostic tests using its proprietary iCHIP® technology
  • The Company’s lead commercial product, SLE-key® is a blood test to assist the physician in ruling out Systemic Lupus Erythematosus
Transaction Overview:
  • ImmunArray and Kindstar will undertake joint clinical testing of up to 500 serum samples from Chinese patients
  • Kindstar will acquire the exclusive rights to market ImmunArray’s SLE-Key Rule-Out® test in China
Significance of the Transaction:
  • Support the clinical implementation of ImmunArray’s SLE-Key Rule-Out® test, which was introduced in the US in 2016
  • Combine the resources of two innovative diagnostic companies that are focused on finding solutions to the diagnosis of autoimmune diseases
Healthios Role:
  • Healthios served as exclusive financial adviser to ImmunArray
  • This transaction highlights Healthios commitment to capital formation in emerging growth companies and our success in completing complex transaction to maximize shareholder interests